[von Willebrand factor (Recombinant)]
Is in your corner
A recombinant von Willebrand factor with an option to dose independently of Recombinant Factor VIII
For each bleeding episode, administer the first dose of VONVENDI with an approved recombinant (non-von Willebrand factor-containing) factor VIII (rFVIII) if FVIII baseline levels are <40% or are unknown. VONVENDI can be administered without rFVIII in some patients if FVIII levels are ≥40% normal activity (0.4 IU/mL) or if an urgent increase is not needed.1
Comprehensive dosing information can be found in the VONVENDI full Prescribing Information.
Get an introduction to VWF function in hemostasis
See what the first recombinant VWF can offer your patients